Aigen Investment Management LP Takes Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Aigen Investment Management LP acquired a new position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,735 shares of the company’s stock, valued at approximately $316,000.

Several other large investors have also recently added to or reduced their stakes in USPH. Vanguard Group Inc. grew its position in U.S. Physical Therapy by 1.0% during the 1st quarter. Vanguard Group Inc. now owns 1,072,602 shares of the company’s stock worth $121,065,000 after acquiring an additional 10,175 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of U.S. Physical Therapy by 2.5% in the second quarter. Dimensional Fund Advisors LP now owns 423,846 shares of the company’s stock valued at $39,173,000 after buying an additional 10,462 shares during the last quarter. Envestnet Asset Management Inc. lifted its position in U.S. Physical Therapy by 4.1% during the 2nd quarter. Envestnet Asset Management Inc. now owns 239,982 shares of the company’s stock worth $22,179,000 after buying an additional 9,434 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in U.S. Physical Therapy by 3.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 157,052 shares of the company’s stock worth $14,515,000 after acquiring an additional 5,111 shares during the last quarter. Finally, Bahl & Gaynor Inc. increased its position in U.S. Physical Therapy by 1.5% in the 2nd quarter. Bahl & Gaynor Inc. now owns 106,476 shares of the company’s stock valued at $9,841,000 after acquiring an additional 1,623 shares in the last quarter.

Insider Activity

In related news, COO Graham D. Reeve sold 1,724 shares of the stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $96.29, for a total transaction of $166,003.96. Following the completion of the sale, the chief operating officer now directly owns 7,106 shares of the company’s stock, valued at approximately $684,236.74. This represents a 19.52 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Bernard A. Harris, Jr. sold 2,000 shares of U.S. Physical Therapy stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $92.95, for a total transaction of $185,900.00. Following the completion of the transaction, the director now directly owns 16,726 shares in the company, valued at approximately $1,554,681.70. The trade was a 10.68 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 8,620 shares of company stock valued at $799,170 in the last ninety days. 1.70% of the stock is owned by insiders.

U.S. Physical Therapy Trading Up 0.2 %

Shares of NYSE USPH opened at $89.95 on Friday. The company’s 50 day simple moving average is $84.19 and its 200 day simple moving average is $91.17. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.88. U.S. Physical Therapy, Inc. has a fifty-two week low of $76.18 and a fifty-two week high of $113.63. The firm has a market capitalization of $1.36 billion, a P/E ratio of 95.69, a P/E/G ratio of 4.15 and a beta of 1.38.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.82 by ($0.09). The company had revenue of $167.19 million during the quarter, compared to the consensus estimate of $163.34 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The firm’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.76 earnings per share. On average, analysts predict that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 15th will be given a dividend of $0.44 per share. The ex-dividend date is Friday, November 15th. This represents a $1.76 annualized dividend and a dividend yield of 1.96%. U.S. Physical Therapy’s payout ratio is currently 187.23%.

Wall Street Analysts Forecast Growth

USPH has been the topic of several research analyst reports. StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st. Bank of America reiterated a “neutral” rating and issued a $90.00 price objective (down from $114.00) on shares of U.S. Physical Therapy in a research report on Monday, October 7th. Finally, Barrington Research restated an “outperform” rating and set a $108.00 target price on shares of U.S. Physical Therapy in a research report on Thursday, November 7th.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.